基因特异性ACMG/AMP分类标准用于生殖线APC变异:ClinGen InSiGHT遗传性结肠癌/多重症变异治愈专家小组的建议
Isabel Spier1, Xiaoyu Yin2, Marcy Richardson3
1Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany; European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS) - Project ID No 739547.
概括
遗传性结直肠癌/多症变异愈专家小组 (VCEP) 制定了新的指导方针,用于解释与家族腺多症相关的APC基因变异. 这些标准减少了不确定的分类,提高了遗传性结直肠癌的诊断准确度.
科学领域:
- 遗传学和基因组学 在
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
背景情况:
- 家族性腺多重症 (FAP) 是一种常见的遗传多重症综合征.
- 精确解释生殖线APC变异对于诊断FAP至关重要.
- 现有的变种分类准则要求对APC进行基因特异性改进.
研究的目的:
- 开发和验证基因特异性推,用于解释生殖系APC变异.
- 改进美国医学遗传学与基因组学学院/分子病理学协会 (ACMG/AMP) 对APC的变异分类准则.
- 改善与遗传性结直肠癌相关的变体的分类.
主要方法:
- 建立了APC变种策划专家小组 (VCEP).
- 严格的数据库分析,文献审查和专家提取.
- 使用试点变种分类推导和验证APC特定标准.
主要成果:
- 开发了APC变种解释的基因和疾病信息标准.
- 实施了对等位基频率的定量方法和切断变异的逐步工具.
- 47%的试点变种被重新分类,其中不确定的意义 (VUS) 的变种减少了56%.
结论:
- 新的APC特定的ACMG/AMP标准有效地减少了VUS,并提高了变种分类的准确性.
- 这些标准保持了良好的特征变异的分类,同时提高了诊断清晰度.
- 该APC VCEP将继续为遗传性结直肠癌的临床使用提供权威的变异分类.
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K


